SeaCrest Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$616K Sell
1,520
-199
-12% -$80.7K 0.07% 266
2025
Q1
$856K Sell
1,719
-24
-1% -$11.9K 0.1% 203
2024
Q4
$907K Buy
1,743
+367
+27% +$191K 0.1% 199
2024
Q3
$851K Sell
1,376
-191
-12% -$118K 0.09% 219
2024
Q2
$867K Sell
1,567
-87
-5% -$48.1K 0.1% 202
2024
Q1
$961K Buy
1,654
+40
+2% +$23.2K 0.12% 185
2023
Q4
$857K Sell
1,614
-1
-0.1% -$531 0.11% 201
2023
Q3
$817K Sell
1,615
-10
-0.6% -$5.06K 0.11% 206
2023
Q2
$848K Sell
1,625
-22
-1% -$11.5K 0.11% 205
2023
Q1
$949K Buy
1,647
+273
+20% +$157K 0.13% 178
2022
Q4
$757K Buy
1,374
+11
+0.8% +$6.06K 0.11% 220
2022
Q3
$691K Sell
1,363
-19
-1% -$9.63K 0.1% 209
2022
Q2
$751K Sell
1,382
-183
-12% -$99.4K 0.09% 217
2022
Q1
$924K Sell
1,565
-61
-4% -$36K 0.11% 200
2021
Q4
$1.09M Buy
1,626
+31
+2% +$20.7K 0.12% 175
2021
Q3
$911K Sell
1,595
-28
-2% -$16K 0.11% 198
2021
Q2
$819K Buy
1,623
+28
+2% +$14.1K 0.1% 219
2021
Q1
$728K Buy
1,595
+24
+2% +$11K 0.1% 226
2020
Q4
$732K Sell
1,571
-109
-6% -$50.8K 0.1% 218
2020
Q3
$742K Sell
1,680
-24
-1% -$10.6K 0.12% 188
2020
Q2
$617K Sell
1,704
-12
-0.7% -$4.35K 0.11% 220
2020
Q1
$487K Buy
1,716
+92
+6% +$26.1K 0.1% 216
2019
Q4
$528K Buy
1,624
+187
+13% +$60.8K 0.09% 268
2019
Q3
$419K Buy
1,437
+105
+8% +$30.6K 0.08% 303
2019
Q2
$391K Buy
1,332
+10
+0.8% +$2.94K 0.08% 310
2019
Q1
$362K Sell
1,322
-170
-11% -$46.6K 0.06% 315
2018
Q4
$334K Sell
1,492
-288
-16% -$64.5K 0.07% 298
2018
Q3
$434K Buy
1,780
+609
+52% +$148K 0.07% 288
2018
Q2
$243K Buy
1,171
+28
+2% +$5.81K 0.04% 426
2018
Q1
$236K Buy
1,143
+118
+12% +$24.4K 0.04% 434
2017
Q4
$195K Buy
+1,025
New +$195K 0.04% 503